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Abstract
Background: High blood pressure is a well established risk factor for morbidity and mortality
acting through heart disease, stroke and cardiovascular disease. Genome wide scans have linked
regions of nearly every human chromosome to blood pressure related traits. We have capitalized
on beneficial qualities of the Old Order Amish of Lancaster, PA, a closed founder population with
a relatively small number of founders, to perform a genome wide homozygosity by descent mapping
scan. Each individual in the study has a non zero probability of consanguinity. Systolic and diastolic
blood pressures are shown to have appreciable dominance variance components.
Results: Areas of two chromosomes were identified as suggestive of linkage to SBP and 5 areas
to DBP in either the overall or sex specific analyses. The strongest evidence for linkage in the
overall sample was to Chromosome 18q12 (LOD = 2.6 DBP). Sex specific analyses identified a
linkage on Chromosome 4p12-14 (LOD in men only = 3.4 SBP). At Chromosome 2q32-33, an area
where we previously reported significant evidence for linkage to DBP using a conventional identity
by descent approach, the LOD was 1.4; however an appreciable sex effect was observed with men
accounting for most of the linkage (LOD in men only = 2.6).
Conclusion: These results add evidence to a sex specific genetic architecture to blood pressure
related traits, particularly in regions of linkage on chromosome 2, 4 and 18.
Background
Hypertension is a common chronic condition in the
United States and leads to severe morbidity and mortality
through heart disease, stroke, congestive heart failure, end
stage renal disease and peripheral vascular disease.
Among these, heart disease and stroke are two of the lead-
ing cause of death in the United States [1,2]. Much effort
and expense has been spent attempting to identify genes
responsible for blood pressure variation and hyperten-
sion. At this point nearly all human chromosomes have
been linked to hypertension related traits through linkage
analysis [3-6]. It seems clear that a single gene is not
responsible for hypertension and that etiology is a com-
plex combination of both genetic and environmental risk
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factors [7,8]. Sex may be an important and easily identifi-
able "environmental" risk factor that may interact with
putative genetic factors to increase risk [9].
To attempt to identify genetic causes to blood pressure
variation and other complex diseases, we have studied a
population of Old Order Amish (OOA) in Lancaster
County, Pennsylvania. The OOA are a closed founder
population with several beneficial qualities for the genetic
study of complex diseases [10]. A relatively homogenous
lifestyle tends to minimize variation of environmental
risk factors associated with high blood pressure such as
high fat diet and low physical activity levels. Furthermore,
other risk factors such as smoking and alcohol consump-
tion appear in very low levels if at all in the OOA commu-
nity. Therefore we hypothesize that genetic determinants
of complex diseases will be easier to identify in an OOA
population where many environmental risk factors do not
have wide variation.
The genetic ancestry of the OOA arises from a small
number of founders, which reduces the genetic complex-
ity and allows for special statistical analyses to be per-
formed. The founders of the OOA population originated
in Western Europe and immigrated to central Pennsylva-
nia in the early 1700s [11]. A recent analysis of the OOA
genealogy indicate that over 95% of the current gene pool
is descendent from fewer than 100 individuals [12]. Mar-
riage into the Amish community is rare and marriage
within the Amish community tends to take place between
members of geographically local church districts. Begin-
ning with the founding of the Amish community in Penn-
sylvania, detailed pedigree records have been maintained
allowing for the OOA population to be connected in a sin-
gle 12–13 generation pedigree.
We previously capitalized on these advantages to map a
quantitative trait locus influencing blood pressure to
chromosome 2q31-34 [13]. Our mapping approach in
that report utilized only a portion of the available 12–13
generation pedigree structure in testing whether the prob-
ability of sharing alleles identical by descent (IBD) across
relative pairs was correlated with their degree of pheno-
typic similarity. In this report, we take more full advantage
of the relatively small number of OOA founders and the
detailed pedigree information in order to assess consan-
guineous relationships and carry out Homozygosity By
Descent (HBD) mapping. In contrast to the more com-
mon IBD linkage analysis, where sharing between individ-
uals is used, HBD mapping looks strictly at sharing within
an individual and correlates phenotypic values with the
probability of an individual having two copies of an
ancestral allele at a given locus. Thus HBD mapping is spe-
cifically designed to detect recessive acting alleles originat-
ing in a founder that possibly lead to an altered
phenotypic expression. It has recently been estimated that
areas of HBD are more common than one would expect in
affected individuals from consanguineous relationships,
which would only act to increase the power of our
approach [14]. We present here the results of HBD map-
ping of the continuous traits systolic and diastolic blood
pressure (SBP and DBP, respectively) among a sample of
OOA individuals. Results from sex specific linkage analy-
sis are also presented. We additionally compare the HBD
mapping results with those obtained from the previous
IBD linkage analysis of these traits in this same popula-
tion.
Results
The study sample consisted of 616 individuals, 31 of
whom were prescribed anti-hypertensive medication at
the time of the study. The age of individuals ranged from
18 to 93 with a mean of 47.4 years. The individuals in the
study had a mean BMI of 27.3 (standard deviation = 4.9).
There were 336 (54.6%) women included.
Previous estimates of the heritability of SBP and DBP
(0.23 and 0.29 respectively) given for this sample of OOA
were of the narrow sense, or the proportion of phenotypic
variation due to the additive effect of genes [13]. Residual
heritability estimates after accounting for age, age2 and sex
with both additive and dominance variance proportions
are given in Table 1 for the four blood pressure traits.
Included in this table are also the heritability estimates of
the naive blood pressure traits if anti-hypertensive medi-
cation use was ignored.
Our HBD mapping identified 2 chromosomal regions
associated with SBP with a LOD score of 2.0 or greater in
either the total combined sample or men and women sep-
Table 1: Proportion of trait variance (standard error) 
attributable to the additive and dominance effect of genes and 
the residual variance attributed to the environment among the 
OOA, Lancaster County PA
Proportion of Variance
Trait Number Mean (SD) 
mmHg
Additive Dominance Environmental
With those on medication removed
SBP 585 121.3 
(15.9)
0.14 (0.12) 0.32 (0.28) 0.54 (0.21)
DBP 585 78.3 (9.2) 0.17 (0.12) 0.25 (0.25) 0.59 (0.18)
Adding a constant to those on medication
SBP 616 123.6 
(19.1)
0.04 (0.13) 0.96 (0.13) 0.00
DBP 616 79.0 (10.1) 0.16 (0.11) 0.46 (0.27) 0.38 (0.21)
Ignoring medication use
SBP 616 123.1 
(18.1)
0.08 (0.12) 0.76 (0.33) 0.17 (0.25)
DBP 616 78.8 (9.8) 0.17 (0.11) 0.37 (0.26) 0.46 (0.20)BMC Genetics 2007, 8:66 http://www.biomedcentral.com/1471-2156/8/66
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Table 2: Genomic areas associated with blood pressure related traits with a LOD score of 1.5 or greater by HBD mapping among the 
OOA, Lancaster County PA
Overall Men Women
Chromosome Peak Position 
(cM)
Removed Adjusted Removed Adjusted Removed Adjusted
Systolic Blood Pressure
3 167 1.6 2.0 1.8
4 64 2.0 3.0 3.4
Diastolic Blood Pressure
2 220 2.5 2.7
3 128 2.3
16 102 2.3 1.6
18 43 2.0 1.8
18 53–55 2.6 2.2 1.8 1.6
Removed = those on medication removed from analysis.
Adjusted = constant added to measured blood pressure of those on medication.
Estimated LOD score obtained from HBD mapping of SBP on Chromosome 4 Figure 1
Estimated LOD score obtained from HBD mapping of SBP on Chromosome 4. Linkage results are given for the overall sample 
and men and women separately. (sbp-med: systolic blood pressure with those on medication removed, sbpAdj = systolic blood 
pressure adjusted for medication as described in text).BMC Genetics 2007, 8:66 http://www.biomedcentral.com/1471-2156/8/66
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arately. Similarly, 5 regions were linked to DBP. These
results are given in Table 2.
Our highest LOD score was found on chromosome 4p14-
12 to SBP (LOD = 3.4). Modest evidence for linkage also
exists to DBP in this area among men (LOD = 1.7). The
linkage in this area is present in men only, see Figure 1.
There is little to no evidence for linkage to either SBP or
DBP in this region among women.
Our highest LOD score for the combined sample (i.e.
both sexes) was on chromosome 18, figure 2. The linkage
is to DBP (LOD = 2.6). There is evidence for linkage in
both sexes, although to different regions on chromosome
18. The linkage heterogeneity between the sexes may be
responsible for the wide peak seen in the overall sample.
Our previous linkage analysis in this sample identified a
region on chromosome 2q 31-34 linked to DBP [13]. The
current HBD mapping analysis identified the same region
on chromosome 2 with a LOD score = 1.4 in the overall
sample with the trait DBP with those on medication
removed, the same trait as initially identified, see Figure 3.
This locus also seems to have significant sex heterogeneity
in the linkage signal, with the linkage in the region being
almost entirely attributable to men. The LOD score = 2.5
when only men are considered in the analysis.
Discussion
Isolated populations have been proposed to be particu-
larly valuable to the mapping of complex traits [15]. We
have used a HBD mapping technique here that is particu-
larly suited for such an isolated population. Our previous
results based upon identity by descent linkage analysis
allow the opportunity to compare directly the two tech-
niques.
Our approach to HBD mapping has been used to identify
genetically linked loci to fasting serum insulin and triglyc-
eride levels in a population of Hutterites, a closed founder
population in South Dakota [16,17]. This study is the first
use of these methods in a population outside of the Hut-
terites. The OOA of Lancaster Pennsylvania and the
Schmiedeleut Hutterites of South Dakota have similar
pedigree structures and levels of consanguinity. Estimates
of inbreeding and kinship coefficients found here in the
OOA are similar to those identified in the Hutterites [18].
The success of these mapping efforts may indicate that
Estimated LOD score obtained from HBD mapping of DBP on Chromosome 18 Figure 2
Estimated LOD score obtained from HBD mapping of DBP on Chromosome 18. Linkage results are given for the overall sam-
ple and men and women separately. (dbp-med: diastolic blood pressure with those on medication removed, dbpAdj = diastolic 
blood pressure adjusted for medication as described in text).BMC Genetics 2007, 8:66 http://www.biomedcentral.com/1471-2156/8/66
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methods developed for either population may be applica-
ble and are computationally manageable in other compa-
rable closed founder populations.
We further investigated the evidence for linkage by plot-
ting the multi-locus probability of HBD against residual
trait values (data not shown). Since homozygosity (by
state) is observable, we were able to assess the genotypes
of the individuals who had high probability of HBD at a
locus and extreme phenotypic values. We were unable to
identify strong evidence for a founder effect in the data.
Our estimates of broad heritability of SBP warrant further
investigation. They indicate that the method used to
account for hypertension medication may have large
effects when estimating variance components of blood
pressure variation. Adding a constant to the measured val-
ues of medicated individuals is the preferred method of
some [19,20]. Our results indicate that after accounting
for age and sex, the residual variance of SBP adjusting for
medication in this way is almost entirely under genetic
control, which is unlikely since measurement error alone
should account for at least some environmental compo-
nent. It should be noted that the standard errors of these
estimates are rather large. Analysis of dominance trait var-
iance in the Hutterites found a significant dominance
component to SBP as well and selected a best fitting
model where the additive component was small. In addi-
tion, other traits, including LDL and Serotonin levels, had
little to no environmental component in the Hutterites
[18].
Estimates of consanguinity and HBD may be underesti-
mated in this analysis. The OOA pedigree available is 12–
13 generations deep and dates back only to the Amish
immigration from Europe to central Pennsylvania. It
assumes all founders, defined as those individuals whose
parents are not represented in the pedigree, are unrelated.
This assumption is conservative, as some of the Amish
founders who emigrated together from Europe may in fact
have been related.
The original ascertainment scheme of our cohort was
based upon the identification of diabetic probands of
Estimated LOD score obtained from HBD mapping of DBP on Chromosome 2 Figure 3
Estimated LOD score obtained from HBD mapping of DBP on Chromosome 2. Linkage results are given for the overall sample 
and men and women separately. (dbp-med: diastolic blood pressure with those on medication removed, dbpAdj = diastolic 
blood pressure adjusted for medication as described in text).BMC Genetics 2007, 8:66 http://www.biomedcentral.com/1471-2156/8/66
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whom family members were recruited into the study.
Therefore it is possible that our cohort is enriched for dia-
betes relevant alleles. Our linkage results presented here
could correspondingly be interpreted as identifying genes
that are linked to blood pressure particularly in the pres-
ence of diabetes susceptibility variants. Interestingly, the p
arm of chromosome 4 has previously been linked to SBP,
as well as to plasma free fatty acid levels, in a sample of
Dutch dyslipidemic families [21], which provides evi-
dence that the association between genes in the region
and blood pressure regulation maybe act through insulin
resistance pathways. For this reason, we choose not to
adjust for diabetic status in our analysis, since we are inter-
ested in finding genes that act on blood pressure, even
those who act primarily via a diabetes related pathway.
We have performed genome wide HBD analysis for four
blood pressure traits in our sample and in strata defined
by sex. These four traits are correlated and the sex strata
overlap with the overall sample analysis. Correspond-
ingly, we present here nominal LOD scores and did not
correct for multiple comparisons between related traits or
overlapping samples.
It has been suggested that many complex quantitative
traits in humans may exhibit a sex specific genetic archi-
tecture [9]. Our results are consistent with this hypothesis
and suggest that blood pressure related traits may have a
sex specific genetic architecture. The present HBD investi-
gation identified a similar region on chromosome 2 as the
previous IBD linkage analysis [13] and sex specific analy-
sis indicates that this linkage may be due to recessive act-
ing alleles in men. Sex specific differences were also seen
in two other regions with evidence for linkage, on chro-
mosomes 4 and 18. The sex specific results on chromo-
some 18 provide enlightening results. The linkage peak in
the overall sample was our most significant result but was
extremely wide, a one LOD interval covering over 22 cM.
Sex specific results identified a narrow peak in the region
among women and two flanking peaks among men. The
male specific linkage peak q-ter of the overall peak, over-
laps with a previously identify region linked to essential
hypertension in Icelandic families [22]. The sex specific
refinement of the linkage peak may aid in the identifica-
tion of responsible genes in the region.
We have identified a similar region on chromosome 2 as
the previously reported identity by descent linkage in this
population. We hesitate to term this second finding as a
"validation" or a "replication" of the initial result because
these are indeed two different analysis asking slightly dif-
ferent questions. In a traditional identity by descent link-
age, regions of the chromosome are identified that related
individuals with similar trait values share identical by
descent more often than expected by chance. The funda-
mental analysis in IBD linkage is between individuals. In
the HBD linkage, we are looking within an individual to
find areas of the genome where an individual's two chro-
mosome are shared identical by descent (thus homozy-
gosity by descent) and then ask whether this region is
linked with a trait of interest. Therefore by definition the
HBD analysis is designed to map recessive acting genetic
effects. So how should we interpret an area of the genome
that supplies evidence of linkage by both methods? One
possibility is there are multiple genes in the region or per-
haps multiple mutations within a single gene that act in
different manners and that the two analyses are identify-
ing two different genetic effects in the same region. Alter-
natively, the two methods may be identifying the same
genetic effect, which is strong enough to be detected by
the two different approaches.
The converse of this question is how to interpret the
results that identify a region of the genome by one analy-
sis but not the other. We found this scenario on chromo-
some 18q. The HBD analysis presented here returned a
LOD of greater than 2 to DBP. Our initial linkage results
found no such evidence on chromosome 18. It is possible
that the genetic effect in this region acts in a purely reces-
sive manner but is not strong enough to be identified by
identity by descent linkage. Alternatively, the possibility
must also be considered that our HBD linkage in this
region is a false positive result or that the identity by
descent linkage is a false negative, each of which would
lead to drastically different conclusions.
Conclusion
How to interpret results from linkage analysis will eventu-
ally come to rest upon issues of a practical nature. Ideally
resources would be available to track down all suggested
areas of linkage with further analysis (fine mapping, can-
didate gene studies, linkage disequilibrium mapping,
etc.). In the case of hypertension and blood pressure
related traits, this would mean investigating nearly every
human chromosome [6]. Since resources are limited,
regions should be identified that hold greatest evidence
across populations and with a variety of analytic tech-
niques. The q arm of chromosome 2 is one such region
identified, particularly to DBP in Caucasian populations
[3]. We present here further evidence for linkage to chro-
mosome 2q in a population of OOA utilizing a HBD map-
ping approach.
Methods
The Amish Family Diabetes Study began in 1995 with the
goal of identifying susceptibility genes for type 2 diabetes
and related traits [23]. The protocol was approved by the
Institutional Review Board of the University of Maryland.
Informed consent was obtained in writing prior to partic-
ipation. Probands were individuals identified with type 2BMC Genetics 2007, 8:66 http://www.biomedcentral.com/1471-2156/8/66
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diabetes and family members over the age of 18 were
recruited into the study. The study protocol was carried
out either in the individual's home or in the Amish Dia-
betes Research Clinic in Strasburg, Pennsylvania. During
the study visit multiple phenotypes were ascertained,
including blood pressure measurements. Systolic (first
phase) and diastolic (fifth phase) blood pressure (SBP
and DBP respectively) were obtained in duplicate by the
use of a standard sphygmomanometer with the subject
sitting for at least 5 minutes and was recorder to the near-
est mmHg.
The use of anti-hypertensive medication is rare in the
OOA community, but it does exist. In our study sample,
31 individuals out of the 616 with blood pressure meas-
urements self-reported anti-hypertension medication use,
only 5% of the sample. We accounted for anti-hyperten-
sive medication use in these analyses using two different
approaches. First, we removed those on medication from
the analysis (annotated bp-med). This method of
accounting for medication was used in the previous study
of blood pressure in this population [13] and was chosen
because anecdotal evidence suggest that compliance to
prescription guidelines are not rigid in the OOA commu-
nity and members tend not to control their blood pressure
tightly with medication. Therefore true underlying blood
pressure levels would be difficult to predict. The second
method used to account for medication was to add a con-
stant to the blood pressure measurements of those pre-
scribed medication (annotated bpAdj). Based on the
effects of anti-hypertensive medication from a double
blind randomized controlled trial [24], Cui et al. (2003)
recommend adding a constant of 10 mmHg to SBP and 5
mmHg to DBP to the observed blood pressures of those
on medication [19]. This method of adjustment for med-
ication has been demonstrated to perform well in a range
of realistic clinical scenarios [20]. Trait residuals were
checked and they were approximately normally distrib-
uted and no outliers were identified.
Participants were genotyped using the ABI Prism Linkage
Mapping Set (Perkin-Elmer), a screen set of 357 high pol-
ymorphic short tandem repeat markers spaced across the
genome at an average distance of 10 cM. The largest gap
between markers is 25.4 cM on chromosome 7. The mark-
ers used here are identical to those used in the previous
linkage study of blood pressure in this population [13].
Statistical Methods
Variance components were used to estimate heritabilities
of the traits. Jacquard's condensed identity coefficients
were computed using an algorithm accounting for the
large inbred population [25,26]. A matrix of Jacquard's
seventh identity coefficient (∆7) was specified to estimate
the proportion of phenotypic variation attributable to the
dominance effect. The ith, jth element in the matrix gives
the probability that individuals i and j share two alleles
IBD and neither of the individuals is autozygous. Poly-
genic additive and dominance variances estimates were
made using the SOLAR software package (Southwest
Foundation for Biomedical Research, San Antonio TX).
Genome wide scans were performed using HBD mapping
methods and software developed by Abney et. al. and
complete statistical methods are described elsewhere [17].
In brief, these methods rely on a non-zero probability of
an individual's parents sharing at least one common
ancestor. The conditional probability of being HBD is
based upon the complete pedigree information and an
individual's multi-locus genotype data and is computed
via a hidden Markov model method. The HBD probability
is included in a linear model as a fixed effect. The linear
model also contains additive and dominance polygenic
variance components. Thus the final model was:
Y = Xβ + γh + g + e
where Y is a vector of individual phenotype values. X is a
design matrix accommodating fixed environmental cov-
ariates and β is a vector of corresponding effect parame-
ters. The h vector contains the multi-point estimates of
HBD at the locus and the γ term is the effect of interest.
The g term is the polygenic component that is distributed
multivariate normally with a mean of zero and a covari-
ance equal to two times the kinship matrix (Φ) times the
expected variance due to the additive effect of genes plus
∆7 matrix times the expected dominance variance.
g ~MVN(0, 2Φσa
2 + ∆7σd
2)
The e term is a normally distributed error component with
mean zero and variance equal to σe
2.
The significance of the HBD effect (Ho: γ = 0) was assessed
at 1 cM intervals across the genome. Because the method
computes p-values directly, to obtain equivalent LOD
scores the nominal p-values were converted to a corre-
sponding chi-square statistic with one degree of freedom
and divided by twice the natural logarithm of 10. Each
model included covariate terms for sex, age and age2. The
sex specific results presented are obtained by including
individuals of one sex only in the analysis.
Sex and age were the only covariates considered for this
analysis for primarily two reasons; firstly, to avoid making
any a priori assumptions regarding the causal mecha-
nisms between the genes and blood pressure levels.
Adjusting for covariates that are associated with both the
exposure (major genes) and the outcome (blood pres-
sure) only makes sense if the covariate is confounding theBMC Genetics 2007, 8:66 http://www.biomedcentral.com/1471-2156/8/66
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association. It is just as likely that any potential covariate
could be on the causal pathway between the major gene
and blood pressure and adjusting for it in the analysis will
increase type II error rate (i.e. produce a false negative).
Since sex can be safely assumed to not lie on any casual
pathway (e.g. it would be difficult to envision a scenario
were a gene "causes" sex), stratifying the results by sex
could add additional insight into major genes effect on
blood pressure. Finally, and of secondary importance, one
aim of this paper was to compare the results from the
HBD mapping exercise directly with the IBD linkage
results previously reported in this sample and thus the
same covariates were used so that a direct comparison
would be valid.
To construct the required pedigree structures for the HBD
calculations, we started with the 616 individuals with
measured blood pressure values participating in the
AFDS, and then added all possible ancestors present in the
Anabaptist Genealogy Database (AGDB) version 3.0 [27].
This process resulted in a single pedigree comprising 6308
individuals. Based on this pedigree the 616 individuals
have a mean (standard deviation) coefficient of consan-
guinity of 0.033 (0.012), and pairwise ∆7 ranging from
2.11 × 10-5 to 0.267 with mean 0.0041. For outbred pop-
ulations ∆7 is 0.25 for siblings.
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